Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - LANNETT CO INC | a16-3373_48ka.htm |
| EX-99.2 - EX-99.2 - LANNETT CO INC | a16-3373_4ex99d2.htm |
| EX-99.4 - EX-99.4 - LANNETT CO INC | a16-3373_4ex99d4.htm |
| EX-99.1 - EX-99.1 - LANNETT CO INC | a16-3373_4ex99d1.htm |
| EX-99.3 - EX-99.3 - LANNETT CO INC | a16-3373_4ex99d3.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-184721) and on Forms S-8 (No. 333-103235, No. 333-103236, No. 333-147410, No. 333-172304, and No. 333-193509) of Lannett Company, Inc. of our report dated February 25, 2015 relating to the financial statements of Kremers Urban Pharmaceuticals Inc., which appears in this Current Report on Form 8-K/A of Lannett Company, Inc.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 11, 2016